Prognosis
Early Covid Treatments Could Be ‘Bridge’ to Vaccine, Fauci Says
- Promising remedies may stop serious lung damage in patients
- New research paves the way for interferon-based therapies
This article is for subscribers only.
We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
Monoclonal antibodies that stop the coronavirus from spreading in the body are among promising strategies for averting severe illness from Covid-19 before vaccines arrive, said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.